Showing 40,561 - 40,580 results of 56,807 for search '(( 09 ((0 decrease) OR (a decrease)) ) OR ( 20 ((we decrease) OR (nn decrease)) ))', query time: 1.18s Refine Results
  1. 40561
  2. 40562
  3. 40563
  4. 40564
  5. 40565
  6. 40566

    Mannose Receptor Deficiency Impacts Bone Marrow and Circulating Immune Cells during High Fat Diet Induced Obesity by Jasmine Nour (14177303)

    Published 2022
    “…<p>  </p> <p>The mannose receptor C-type 1 (Mrc1) is a C-type lectin receptor expressed on the immune cells and sinusoidal endothelial cells of several tissues. In this study, we used <em>Mrc1</em>−/− mice and wild-type (WT) littermates fed on a high-fed diet (HFD) for 20 weeks.  …”
  7. 40567

    Presentation_1_Unraveling the Novel Protective Effect of Patchouli Alcohol Against Helicobacter pylori-Induced Gastritis: Insights Into the Molecular Mechanism in vitro and in vivo... by Da-wei Lian (6001349)

    Published 2018
    “…In the in vivo experiment, a C57BL/6 mouse model of gastritis was established using H. pylori SS1, and treatments with standard triple therapy or 5, 10, and 20 mg/kg PA were performed for 2 weeks. Results indicated that PA effectively attenuated oxidative stress by decreasing contents of intracellular reactive oxygen species (ROS) and malonyldialdehyde (MDA), and increasing levels of non-protein sulfhydryl (NP-SH), catalase and glutathione (GSH)/glutathione disulphide (GSSG). …”
  8. 40568
  9. 40569
  10. 40570
  11. 40571
  12. 40572
  13. 40573

    The pool of premyelinating OL lineage cells is significantly increased following rHI; PreOLs are less susceptible to acute degeneration following rHI than following late HI. by Matthew W. Hagen (627944)

    Published 2014
    “…(D) Stereology further shows a decreased rate of preOL death following rHI relative to late HI (Kruskal-Wallis: H = 7.5, p = 0.057, on 3 df; mean ± SD Control: 0.9±0.4%; Early HI: 1.2±0.9%; Late HI: 5.0±2.4%; rHI: 1.7±1.8%; Bonferroni-corrected post-hoc Mann-Whitney U-tests: *Late HI vs. …”
  14. 40574
  15. 40575

    DataSheet1_Combined effects of mixing ratios and tree size: how do mixed forests respond to climate and drought events?.docx by Xiaoxia Wang (14667)

    Published 2024
    “…In the temperate region of China, we investigated three mixing ratios: 90% P and 10% Q (P9Q1), 60% P and 40% Q (P6Q4), and 20% P and 80% Q (P2Q8). …”
  16. 40576

    Table1_Short hydrocarbon stapled ApoC2-mimetic peptides activate lipoprotein lipase and lower plasma triglycerides in mice.docx by Denis Sviridov (4630546)

    Published 2023
    “…We recently described a dual ApoC2 mimetic/ApoC3 antagonist peptide called D6PV that effectively lowered TG in several mouse models but has limitations in terms of drug development. …”
  17. 40577

    Table_1_Association of APOE ε4/ε4 with fluid biomarkers in patients from the PUMCH dementia cohort.DOCX by Li Shang (159550)

    Published 2023
    “…Furthermore, we did not find any associations of APOE ε4 with plasma biomarkers of AD and non-AD. …”
  18. 40578

    The NEAT1/miR-124-3p/CCL2 axis in chronic kidney disease progression: integrated bioinformatics analysis and experimental validation by Guanting Chen (19476017)

    Published 2025
    “…Our tests showed that NEAT1 “catches” miR-124-3p, stopping itfrom reducing CCL2. When we checked blood levels in 64 CKD patients, we sawthat as kidney function got worse, NEAT1 and miR-124-3p went down while CCL2went up.…”
  19. 40579

    STMs for speech in impaired listeners (Venezia et al., 2019) by Jonathan H. Venezia (425218)

    Published 2019
    “…We recruited 3 groups of participants: 20 older hearing-impaired (OHI) listeners, 19 age-matched normal-hearing listeners, and 10 young normal-hearing (YNH) listeners. …”
  20. 40580

    Datasheet1_Short hydrocarbon stapled ApoC2-mimetic peptides activate lipoprotein lipase and lower plasma triglycerides in mice.zip by Denis Sviridov (4630546)

    Published 2023
    “…We recently described a dual ApoC2 mimetic/ApoC3 antagonist peptide called D6PV that effectively lowered TG in several mouse models but has limitations in terms of drug development. …”